Lumos Pharma Inc (LUMO)
Market Closed
11 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 34
0
0%
$
37.54M Market Cap
- P/E Ratio
- Div Yield
390,873 Volume
-4.15 Eps
$ 4.34
Previous Close Want to track LUMO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lumos Pharma, Inc. (LUMO) Q2 2024 Earnings Call Transcript
Lumos Pharma, Inc. (NASDAQ:LUMO ) Q2 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Lisa Miller - Vice President, Investor Relations Rick Hawkins - Chief Executive Officer and Chairman John McKew - President and Chief Scientific Officer Lori Lawley - Chief Financial Officer Duke Pitukcheewanont - Chief Medical Officer Conference Call Participants Catherine Novack - Jones Trading Leland Gershell - Oppenheimer Charles Duncan - Cantor Fitzgerald Operator Good afternoon and welcome to Lumos Pharma's Second Quarter 2024 Financial Results and Clinical Programs Update Call. Currently, all participants are in a listen-only mode.
Seekingalpha | 1 year ago
